The utility of high-risk human papillomavirus E6/E7 mRNA in situ hybridization in assessing HPV status on cell block
Assessment of human papillomavirus (HPV) status is critical to the treatment and prognosis of patients with oropharyngeal squamous cell carcinoma. Patients often present with enlarged cervical lymph nodes which are amenable to fine needle aspiration (FNA) and cell block creation. The most widely use...
Gespeichert in:
Veröffentlicht in: | Journal of the American Society of Cytopathology JASC 2021-03, Vol.10 (2), p.225-230 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Assessment of human papillomavirus (HPV) status is critical to the treatment and prognosis of patients with oropharyngeal squamous cell carcinoma. Patients often present with enlarged cervical lymph nodes which are amenable to fine needle aspiration (FNA) and cell block creation. The most widely used method for assessing HPV status is the surrogate marker p16. Other HPV specific methods such as high-risk HPV E6/E7 mRNA in situ hybridization (ISH) have been shown to perform as well as p16 and are easier to interpret. Our study evaluates the utility of high-risk HPV mRNA ISH in cell block specimens.
Thirty-six cases of metastatic squamous cell carcinoma in cervical neck lymph node FNAs were identified over a 3-year period. All cases had p16 immunohistochemistry (IHC) performed on cell block. HR HPV mRNA ISH was performed on the cell block and compared to the p16 results. Additionally, p16 and HR HPV mRNA ISH status was assessed in those cases with corresponding surgical resections.
HR HPV mRNA ISH confirmed the p16 IHC (either positive or negative) in 24 of the 36 cases (66.7%). Six false negative cases were p16 negative/HR HPV mRNA ISH positive. HR HPV mRNA ISH was positive in 75% of the four p16 equivocal cases. Two cases were p16 positive/HR HPV mRNA ISH negative.
HR HPV mRNA ISH is no more difficult to perform in the IHC lab and is easier to interpret than p16 IHC. HR HPV mRNA ISH is a useful alternative to p16 in cell block specimens.
•Accurate assessment of HPV status in cell block has important therapeutic and prognostic implications for patients with oropharyngeal squamous cell carcinoma as cytology specimens may be the first or only tissue received.•While p16 is the most widely used surrogate marker for HPV, variability in interpretation has somewhat limited it’s utility in cell block. HR HPV mRNA ISH is HPV specific and easier to interpret.•HR HPV mRNA ISH is a useful alternative to p16 in cell block specimens.
[Display omitted] |
---|---|
ISSN: | 2213-2945 2213-2945 |
DOI: | 10.1016/j.jasc.2020.09.007 |